WE'RE FOCUSED ON SIX STRATEGIC PILLARS

The Group's six strategic pillars are fundamental to everything we do at Clinigen.

By linking our day-to-day activities as well as our long term priorities to these six pillars we able to ensure there is a clear and consistent pathway to growth for the business.

The pillars provide clarity for all our stakeholders on the key initiatives across the business, why we are doing them and how success will be measured. They are also linked to our Environmental, Social and Governance approach where key priorities and goals can sit within both the strategic pillars and the ESG framework.

1. Cultivate a thriving high performance culture

2021 Progress

  • >80% of employees have personal development plans
  • 110 individuals completed Management Academy
  • >95% of roles advertised internally
  • >60 internal promotions during FY2021
  • 10% increase on average training spend per employee
  • Launched new e-learning program on career development for employees and managers
  • Roll-out of job grading framework across Group
  • Conducted talent and succession planning review across the Group
  • New COO in place to drive operational change

Performance Metrics

2022 Objectives

  • Roll out of leadership academy for business leaders
  • Next cohort for Management Academy
  • Development of hybrid working practices
  • Continued focus on talent and succession planning
  • Embedding of job grading across group
  • Launch of CALM – wellness app for all employees
  • Introduction of flexible benefits platform

Link to ESG Model

2. Drive operational excellence

2021 Progress

  • Successful implementation of Brexit solution
  • Conducted global review of supply chain to enable optimisation of current partners and hubs
  • Simplification of organisation from three divisions to two divisions to drive synergies
  • Expansions of US, EU hubs’ deep ultra-cold storage
  • Disposal of UK Specials and Aseptic business to ensure operational focus
  • Introduced process governance structure
  • Introduced Internal Audit and Risk function
  • Launch of serialisation in the US

Performance Metrics

2022 Objectives

  • Utilise AI technology to monitor supply chain cost and service levels in real time
  • Continue to develop synergies between Divisions and Businesses through development and integration to drive value for clients and customers

Link to ESG Model

3. Partner with clients to deliver synergistic value

2021 Progress

  • Increase in clients utilising more than one part of the platform
  • 10 successful cross- divisional referrals to drive value for existing clients
  • Increased total number of clients that have utilised Clinigen platform over last 12 months
  • Initiation of Erwinase roll-out ahead of schedule
  • Launch of Hunterase in Japan

Performance Metrics

2022 Objectives

  • Pipeline of 15 additional companies that are at proposal stage for utilising more than one part of the Clinigen platform
  • Further focus on securing Partnering deals with existing Services clients
  • Driving cross divisional referrals and Group client approaches

Link to ESG Model

4. Lead the market in customer experience

2021 Progress

  • Held first ‘Love Your Pharmacist’ Awards’ to the recognise work done by HCPs
  • Customer workshops to inform direction of e-commerce platform
  • Pivoted focus to provide multiple COVID-19 solutions for pharma clients and HCPs

Performance Metrics

2022 Objectives

  • Customer loyalty and satisfaction benchmarking
  • Process excellence in OTIF
  • Utilise MSL network to educate specialist prescribers
  • Continued enhancement of client services team across Services division to deliver on existing and new business

Link to ESG Model

5. Enhance the portfolio of assets, services and territories

2021 Progress

  • Highest number of Managed Access Programs added to portfolio than ever before
  • Record number and value of business wins in Clinical packaging and logistics
  • Strong growth in number of Partnered products being managed
  • Roll-out of Patient Fellowship to change behaviours in early access
  • Opening of Malaysia office to strengthen presence in Asia

Performance Metrics

2022 Objectives

  • Expansion into China and Korea through business partnership or ‘go alone’ strategies
  • Further roll-out of Developed products and SKUs
  • Roll-out of Erwinase into additional licenced markets including the USA
  • Further portfolio growth across Managed Access and Partnered

Link to ESG Model

6. Realise competitive advantage through technology

2021 Progress

  • Implementation of new CRM platform to support BD activities
  • Beta release of Clinigen Direct delivered
  • First full Clinigen Direct service release
  • Continued enhancements of ClinigenOne ERP platform

Performance Metrics

2022 Objectives

  • Roll-out of Clinigen Directinto key markets
  • Enhanced data platform and insight tools to provide deeper customer insights
  • Transition Managed Access clients and HCPs onto Clinigen Direct
  • Further CRM roll-out to global business

Link to ESG Model